RB1 loss was most frequent in HGSC (16.4%), followed by endometrioid ovarian carcinoma (ENOC; 4.1%, χ2P < 0.0001; Fig. 1B). This evidence concerns the gene RB1 and ovarian endometrioid carcinoma.